Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

Share Price is delayed by 15 minutes
Get Live Data
7.40    0.00 (0.00%)
Bid:
7.30
Ask:
7.50
Spread: 0.20 (2.74%)
Market Cap: £3.24m
FDBK Live PriceLast checked at - London Stock Exchange

Intraday Feedback Share Chart

Director/PDMR Shareholding

17 Aug 2018 14:02

RNS Number : 1943Y
Feedback PLC
17 August 2018
Β 

17 August 2018

Feedback plc

("Feedback" or the "Company")

Β 

Director/PDMR Shareholding

Feedback plc, the specialist medical imaging technology company, announces that Mike Hayball, a PDMR of the Company, on 15 August 2018 sold 250,000 shares in the Company at a price of 2.2 pence per share and on 16 August 2018 sold 250,000 shares in the Company at a price of 2.0 pence per share and 150,000 shares at a price of 2.2p per share. Following the sales, Mike Hayball holds 4,520,600 shares in the Company, representing approximately 1.61 per cent of the Company's issued share capital.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Hayball

2

Reason for the notification

a)

Position/status

PDMR

b)Β 

Initial notification /Amendment

Initial notification

3Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Feedback plc

b)

LEI

213800UGOF2GT2U2RV90

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.25p each in Feedback plc

Β 

Identification code (ISIN) for Feedback plc ordinary shares: GB0003340550Β 

b)

Nature of the transaction

Sale of sharesΒ 

c)

Price(s) and volume(s)

Β Price(s)

Volume(s)

2.2pΒ 

2p

2.2p

250,000 on 15 August 2018

250,000 on 16 August 2018

150,000 on 16 August 2018

Β 

d)

Aggregated information

- Aggregated volume

- Price

Β Price(s)

Volume(s)

2.12p

650,000

Β 

e)

Date of the transaction

15 and 16 August 2018

f)

Place of the transaction

London Stock Exchange, XLON

Β 

For further information, please contact:

Feedback plc

Alastair Riddell, Executive Chairman

Β 

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser and Joint Broker)

David Worlidge / Asha Chotai

Β 

+44 (0)20 3328 5656

Peterhouse Corporate Finance Ltd (Joint Broker)

Lucy Williams / Duncan Vasey

Β 

+44 (0)20 7469 0936

Instinctif Partners

Melanie Toyne Sewell / Rozi Morris

+44 (0)20 7457 2020

feedbackplc@instinctif.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHGGUGURUPRGWM
Date   Source Headline
21st Mar 20247:00 amRNSFurther CDC Pilot Programme Secured
23rd Feb 202411:03 amRNSHolding(s) in Company
21st Feb 20247:00 amRNSHalf-year Report
21st Feb 20247:00 amRNSMedical Imaging Partnership Pilot Agreement
6th Feb 20247:00 amRNSNotice of Results & Investor Presentation
19th Dec 20237:01 amRNSHalf Year Trading Update
19th Dec 20237:00 amRNSAward of Pilot Funding
26th Oct 20232:24 pmRNSResult of AGM
25th Oct 20235:53 pmRNSDirector Dealing
27th Sep 202312:15 pmRNSNotice of AGM
12th Sep 20237:00 amRNSFinal Results
5th Sep 20237:00 amRNSNotice of Results & Investor Presentation
19th Jun 20237:00 amRNSYear End Trading Update
4th Apr 20237:00 amRNSBleepa-CareLocker contract extension with QVH
7th Feb 20237:00 amRNSHalf-year Report
3rd Feb 20233:56 pmRNSHolding(s) in Company
11th Jan 20237:00 amRNSNotice of Results, Analyst & Investor Presentation
22nd Dec 202212:08 pmRNSDirector/PDMR Shareholding: Correction
22nd Dec 20227:00 amRNSDirector/PDMR Shareholding
19th Dec 20227:00 amRNSHalf Year Trading Update
1st Nov 20223:36 pmRNSTotal Voting Rights
13th Oct 20222:55 pmRNSResult of AGM & Proposed Share Consolidation
29th Sep 20223:46 pmRNSHolding(s) in Company
20th Sep 20223:26 pmRNSNotice of AGM & Proposed Share Consolidation
20th Sep 20227:00 amRNSFinal Results
13th Sep 20227:00 amRNSNotice of Results & Investor Presentation
6th Sep 20227:00 amRNS12 month contract for Sussex CDC pilot extension
19th Jul 20227:00 amRNSContract Update
16th Jun 20227:00 amRNSYear End Trading Update
1st Jun 20227:00 amRNSTrading Update & Director Appointment
12th May 202212:44 pmRNSChange of Registered Office
12th Apr 20227:00 amRNSBleepa wins two NHS Contract Awards
31st Mar 20227:00 amRNSBleepa TB Screening Pilot Now Live in Odisha
23rd Feb 20227:00 amRNSGrant of Options and PDMR dealing
10th Feb 20227:00 amRNSInterim Results
31st Jan 20227:00 amRNSNotice of Results
13th Dec 20217:00 amRNSPartnership with Amazon Web Services
6th Dec 20213:06 pmRNSHolding(s) in Company
2nd Dec 202110:20 amRNSDirector/PDMR Shareholding
2nd Dec 20219:54 amRNSHolding(s) in Company
1st Dec 20214:27 pmRNSHolding(s) in Company
1st Dec 20213:09 pmRNSHolding(s) in Company
30th Nov 20214:05 pmRNSHolding(s) in Company
29th Nov 20211:36 pmRNSDirector Appointment
29th Nov 20211:35 pmRNSResults of AGM, Open Offer, Issue of Equity & TVR
18th Nov 202112:15 pmRNSHolding(s) in Company
16th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20211:52 pmRNSResult of Placing
2nd Nov 20217:01 amRNSProposed Placing and Open Offer
2nd Nov 20217:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.